68 related articles for article (PubMed ID: 8832146)
21. Factors involved in the loss of bone mineral density after renal transplantation.
Torregrosa JV; Campistol JM; Montesinos M; Fenollosa B; Pons F; Martinez de Osaba MJ; Oppenheimer F
Transplant Proc; 1995 Aug; 27(4):2224-5. PubMed ID: 7652782
[No Abstract] [Full Text] [Related]
22. Bone density in renal transplant recipients and in patients with chronic kidney disease: a follow-up study in children and adolescents.
Cvijetic S; Slavicek J; Karacic I; Puretic Z; Kes P
Clin Nephrol; 2010 Mar; 73(3):197-203. PubMed ID: 20178718
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density profile in uremic and renal transplant patients.
Chao SH; Tsai KS; Chieng PU; Lee PH; Lee CJ; Lee CS
Transplant Proc; 1994 Aug; 26(4):2009-11. PubMed ID: 8066651
[No Abstract] [Full Text] [Related]
24. Bone alkaline phosphatase in children with chronic renal failure.
Behnke B; Kemper M; Kruse HP; Müller-Wiefel DE
Nephrol Dial Transplant; 1998 Mar; 13(3):662-7. PubMed ID: 9550644
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting bone mineral density in renal transplant patients.
Caglar M; Adeera L
Ann Nucl Med; 1999 Jun; 13(3):141-5. PubMed ID: 10435373
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density in children with primary hyperoxaluria type I.
Behnke B; Kemper MJ; Kruse HP; Müller-Wiefel DE
Nephrol Dial Transplant; 2001 Nov; 16(11):2236-9. PubMed ID: 11682674
[TBL] [Abstract][Full Text] [Related]
27. [The mineral content of bone and the activity of alkaline bone phosphatase in renal bone disease treated with dialysis and after kidney transplantation].
Koall W; Mampel E; Hintner I; Runge H
Z Gesamte Inn Med; 1978 Jun; 33(12):403-6. PubMed ID: 356443
[No Abstract] [Full Text] [Related]
28. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.
Briner VA; Thiel G; Monier-Faugere MC; Bognar B; Landmann J; Kamber V; Malluche HH
Transplantation; 1995 May; 59(10):1393-400. PubMed ID: 7770924
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal changes in radial bone density in older men.
Overton TR; Basu TK
Eur J Clin Nutr; 1999 Mar; 53(3):211-5. PubMed ID: 10201803
[TBL] [Abstract][Full Text] [Related]
30. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.
Hutchison AJ; Whitehouse RW; Boulton HF; Adams JE; Mawer EB; Freemont TJ; Gokal R
Kidney Int; 1993 Nov; 44(5):1071-7. PubMed ID: 8264137
[TBL] [Abstract][Full Text] [Related]
31. Parathyroidectomy does not affect bone aluminum in chronic renal failure.
Nordal KP; Dahl E; Halse J; Hartmann A; Flatmark A
Transplant Proc; 1992 Feb; 24(1):369-70. PubMed ID: 1539321
[No Abstract] [Full Text] [Related]
32. Bone mineral density after renal transplantation: long-term follow-up.
Moreno A; Torregrosa JV; Pons F; Campistol JM; Martínez de Osaba MJ; Oppenheimer F
Transplant Proc; 1999 Sep; 31(6):2322-3. PubMed ID: 10500599
[No Abstract] [Full Text] [Related]
33. Bone densitometry using computed tomography. Part II: increased trabecular bone density in children with chronic renal failure.
Exner GU; Prader A; Elsasser U; Anliker M
Br J Radiol; 1979 Jan; 52(613):24-8. PubMed ID: 427347
[TBL] [Abstract][Full Text] [Related]
34. Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure.
Kis E; Cseprekál O; Bíró E; Kelen K; Ferenczi D; Kerti A; Szabó AJ; Szabó A; Reusz GS
Pediatr Nephrol; 2009 Dec; 24(12):2413-20. PubMed ID: 19763629
[TBL] [Abstract][Full Text] [Related]
35. Long term follow-up of bone mineral status in children with renal disease.
Chesney RW; Rose P; Mazess RB; DeLuca HF
Pediatr Nephrol; 1988 Jan; 2(1):22-6. PubMed ID: 3152995
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of bone mass after renal transplant with preemptive care.
Hurst G; Alloway R; Hathaway D; Somerville T; Hughes T; Gaber A
Transplant Proc; 1998 Jun; 30(4):1327-8. PubMed ID: 9636539
[No Abstract] [Full Text] [Related]
37. Clinical evaluation of bone metabolism after renal transplantation to support the theory to perform 1,25(OH)2D3 pulse therapy before transplantation.
Hyodo T; Kumano K; Endo T; Mori T; Takagi Y; Mashimo S; Sakai T; Koshiba K
Nephron; 1996; 73(4):723. PubMed ID: 8856286
[No Abstract] [Full Text] [Related]
38. Cortical and trabecular bone in pediatric end-stage kidney disease.
Carvalho CG; Pereira RC; Gales B; Salusky IB; Wesseling-Perry K
Pediatr Nephrol; 2015 Mar; 30(3):497-502. PubMed ID: 25185885
[TBL] [Abstract][Full Text] [Related]
39. Evolution of bone stiffness in renal transplant patients measured by quantitative ultrasound.
Kosch M; Kisters K; Hausberg M
Clin Nephrol; 2003 Feb; 59(2):147-8. PubMed ID: 12608559
[No Abstract] [Full Text] [Related]
40. Physical bone changes in carragheenin-induced arthritis evaluated by quantitative computed tomography.
Søballe K; Pedersen CM; Odgaard A; Juhl GI; Hansen ES; Rasmussen HB; Hvid I; Bünger C
Skeletal Radiol; 1991; 20(5):345-52. PubMed ID: 1896875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
